1. "Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial". Issue 7 (July 2020) Authors: Taïeb, Julien; Benhaim, Léonor; Laurent Puig, Pierre; Le Malicot, Karine; Emile, Jean François; Geillon, Flore; Tougeron, David; Manfredi, Sylvain; Chauvenet, Marion; Taly, Valerie; Lepage, Côme; André, Thierry Journal: Digestive and liver disease Issue: Volume 52:Issue 7(2020) Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK). Issue 3 (March 2018) Authors: Michel, Pierre; Boige, Valerie; Andre, Thierry; Aparicio, Thomas; Bachet, Jean Baptiste; Dahan, Laetitia; Guimbaud, Rosine; Lepage, Côme; Manfredi, Sylvain; Tougeron, David; Taieb, Julien; Selves, Janick; Le Malicot, Karine; Di Fiore, Frederic; Maillard, Emilie Journal: Digestive and liver disease Issue: Volume 50:Issue 3(2018) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial. Issue 3 (March 2021) Authors: Taïeb, Julien; André, Thierry; El Hajbi, Farid; Barbier, Emilie; Toullec, Clémence; Kim, Stefano; Bouche, Olivier; Di Fiore, Frederic; Chauvenet, Marion; Perrier, Hervé; Evesque, Ludovic; Laurent-Puig, Pierre; Emile, Jean-François; Bez, Jérémie; Lepage, Côme; Tougeron, David Journal: Digestive and liver disease Issue: Volume 53:Issue 3(2021) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bevacizumab plus FOLFIRI after failure of platinum–etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial. Issue 3 (March 2023) Authors: Walter, Thomas; Lievre, Astrid; Coriat, Romain; Malka, David; Elhajbi, Farid; Di Fiore, Fréderic; Hentic, Olivia; Smith, Denis; Hautefeuille, Vincent; Roquin, Guillaume; Perrier, Marine; Dahan, Laetitia; Granger, Victoire; Sobhani, Iradj; Mineur, Laurent; Niccoli, Patricia; Assenat, Eric; Scoazec... Journal: Lancet oncology Issue: Volume 24:Issue 3(2023) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chemotherapy of metastatic colon cancer in France: A population-based study. Issue 10 (October 2021) Authors: Mas, Léo; Bachet, Jean-Baptiste; Jooste, Valérie; Lepage, Côme; Bouvier, Anne-Marie Journal: Digestive and liver disease Issue: Volume 53:Issue 10(2021) Page Start: 1334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. Issue 9 (10th September 2013) Authors: Allemani, Claudia; Rachet, Bernard; Weir, Hannah K; Richardson, Lisa C; Lepage, Côme; Faivre, Jean; Gatta, Gemma; Capocaccia, Riccardo; Sant, Milena; Baili, Paolo; Lombardo, Claudio; Aareleid, Tiiu; Ardanaz, Eva; Bielska-Lasota, Magdalena; Bolick, Susan; Cress, Rosemary; Elferink, Marloes; Fulton... Journal: BMJ open Issue: Volume 3:Issue 9(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study. Issue 7 (July 2015) Authors: Drouillard, Antoine; Bouvier, Anne-Marie; Rollot, Fabien; Faivre, Jean; Jooste, Valérie; Lepage, Côme Journal: Digestive and liver disease Issue: Volume 47:Issue 7(2015) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Copy number variations in DCC/18q and ERBB2/17q are associated with disease‐free survival in microsatellite stable colon cancer. Issue 7 (1st April 2017) Authors: Sefrioui, David; Vermeulin, Thomas; Blanchard, France; Chapusot, Caroline; Beaussire, Ludivine; Armengol‐Debeir, Laura; Sesboué, Richard; Gangloff, Alice; Hebbar, Mohamed; Copin, Marie‐Christine; Houivet, Estelle; Schwarz, Lilian; Clatot, Florian; Tuech, Jean‐Jacques; Bénichou, Jacques; Martin, L... Journal: International journal of cancer Issue: Volume 140:Issue 7(2017:Apr. 01) Page Start: 1653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial. Issue 7 (July 2015) Authors: Lepage, Côme; Phelip, Jean-Marc; Cany, Laurent; Faroux, Roger; Manfredi, Sylvain; Ain, Jean-Francois; Pezet, Denis; Baconnier, Mathieu; Deguiral, Philippe; Terrebone, Eric; Adenis, Antoine; Le Malicot, Karine; Bedenne, Laurent; Bouché, Olivier Journal: Digestive and liver disease Issue: Volume 47:Issue 7(2015) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluating bevacizumab in combination with FOLFIRI after the failure of platinum-etoposide regimen in patients with advanced poorly differentiated neuroendocrine carcinoma: The PRODIGE 41–BEVANEC randomized phase II study. Issue 2 (February 2018) Authors: Walter, Thomas; Malka, David; Hentic, Olivia; Lombard-Bohas, Catherine; Le Malicot, Karine; Smith, Denis; Ferru, Aurélie; Assenat, Eric; Cadiot, Guillaume; Lievre, Astrid; Kurtz, Jean-Emmanuel; Dahan, Laetitia; Dubreuil, Olivier; Hautefeuille, Vincent; Lepere, Céline; Gangloff, Alice; Elhajbi, Fa... Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018) Page Start: 195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗